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Pulmonary Tuberculosis Treatment Outcomes in HIV
Infected Patients on Antiretroviral Therapy
Supat Chamnachanan1, Aung Kay Tu1, Somsit Tansuphasawadikul2,
Benjaluck Phonrat1, Punnee Pitisuttithum1, Jittima Dhitavat1.
1Department of Tropical Medicine, Faculty of Tropical Medicine,
Mahidol University, Bangkok, Thailand; 2Bamrasnaradura
Institute, Ministry of Public Heath, Nonthaburi, Thailand
Background: Tuberculosis (TB) is the most common opportunistic
infection (OI) in HIV-infected patients. There are effective regimes
for HIV and TB infection, but the concomitant treatment is diffi-
cult due to adverse effects, drug interaction, and worsening con-
dition. Not all anti-TB drugs are available in developing countries.
This study describes treatment outcomes of pulmonary TB in HIV-
infected patients on antiretroviral therapy (ART).
Materials and Methods: This retrospective study was done at Bam-
rasnaradura Institute, Bangkok. The study was conducted among
TB and HIV co-infected patients, aged 15 years and older, who
received both anti-TB and ART (NNRTI-base). The patients were
admitted in this institute from January 1, 2003 to December 31,
2004.
Results: Sixty-five patients (47 male) with a median age of 32 years
old (range 20-58) was entered into the study. When the TB was
diagnosed, the median CD4 count was 33 cells/ul (range 2-342).
Fifty patients (76.92%) received standard anti-TB (HRZE) regimes
for at least 2 months in the initial phase and fifteen patients
(23.08%) did not receive regimes as above. ART was initiated at
a median of 12 weeks (range 0-52) of TB treatment. Eight patients
(12.3%) had already received ART before the TB diagnosis. Forty-
three (66.1%) and 22 (33.9%) patients received nevirapine (NVP)
and efervirenz (EFV) based regimes, respectively. Thirty-six pa-
tients (55.4%) received NVP and rifampicin (RFP) concurrently, and
the median of overlapping day was 115 (range 5-394). Drug tox-
icity was observed in 26 patients (40%). There was no significant
association between drug toxicity and concurrent use of NVP and
RFP. Five patients (7.7%) had immune reconstitution syndrome and
4 patients (6.2%) had OI after ART. Thirty-three patients (50.8%)
were clinically cured, 20 (30.8%) were cured, 5 (7.7%) were trans-
ferred out, 3(4.6%) had treatment interrupted, 3 (4.6%) died and 1
patient had treatment. There were no associations between treat-
ment outcomes and anti-TB regimes, ART regimes and concurrent
use of NVP and RFP, but initiating ART before or during TB treat-
ment was significantly associated with favorable treatment out-
comes.
Conclusions: Initiation of ART in the early course of HIV infection,
before TB infection, yields a favorable pulmonary TB treatment
outcome. NVP-based ART is an option for HIV-infected patients re-
ceiving RFP. This result is expected to be beneficial for medical
personals involved in HIV patients especially in developing coun-
tries.
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Introduction: The current estimate of the burden of typhoid fever
in Africa is based on population-based studies from Egypt and
South Africa and no estimate is available for invasive non-Typhi
Salmonella (NTS). To gain initial insights into the epidemiology of
invasive salmonellosis in East Africa, we studied febrile admissions
at three hospitals in northern Tanzania.
Methods: We enrolled consecutive febrile patients aged 2 months
to 13 years at Teule District Hospital (TDH), Muheza, and at Kili-
manjaro Christian Medical Centre (KCMC), Moshi, and febrile pa-
tients aged 13 years and above at KCMC and Mawenzi Regional
Hospital (MRH), Moshi. All patients received a standardized clin-
ical history and physical examination, aerobic blood culture, and
HIV antibody testing.
Results: Of 3,664 children admitted to TDH, 319 (8.7%) were bac-
teremic of whom 23 (16%) were HIV antibody-positive on a sin-
gle test, 161(50.5%) had NTS and 9 (2.8%) had S. Typhi blood-
stream infection. Of 33 bacteremic children identified at KCMC,
9 (27%) were HIV-infected, 1 (%) had NTS and 10 (30%) had S. Ty-
phi bloodstream infection. Of 52 bacteremic adults identified at
KCMC and MRH, 20 (39%) were HIV-infected, 5 (9.6%) had NTS and
16 (30.8%) had S. Typhi bloodstream infection. In KCMC and MRH,
NTS bacteremia was associated with HIV seropositivity in all age
groups, 6 patients with NTS were HIV infected, but not with S.Typhi
bacteremia. In TDH, NTS infection was also associated with HIV-
positivity (OR 1.3, p=0.059) but none of the 9 S. Typhi infections
occurred in an HIV-positive child.
Conclusions: The relative importance of S. Typhi and of NTS as
causes of bloodstream infection among febrile, hospitalized pa-
tients varies considerable between two sites in northern Tanzania.
NTS but not S.Typhi bloodstream infection is strongly associated
with HIV infection. Understanding burden of invasive NTS and S. Ty-
phi in Africa requires an approach that addresses considerable epi-
demiologic heterogeneity and that accounts for the influence of
HIV seroprevalence.
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Background: Pediatric antiretroviral therapy is provided in all pri-
mary health care facilities in Cameroon. Despite scale-up of these
perinatal prevention efforts, many children still become infected
with the human immunodeficiency virus (HIV). This study assessed
the impact of antiretroviral therapy (ART) on the clinical and im-
munologic outcomes of children in Cameroon.
